Skip to main content

Table 1 Verification of LOD with clinical samples

From: Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples

  MPS Idylla™ KRAS Mutation Test
16S106 G12C (10% TTC: 31%VAF) G12C
16K11 G12C (5-10% TTC: 33% VAF) G12C
16O1048 G12V (10% TTC; 3% VAF) G12V
16EM117 G12D (10% TTC, 18%VAF) G12D
  1. TTC tumor tissue content, VAF variant allele frequency